Lyra Therapeutics (LYRA) Current Assets (2019 - 2025)
Quarterly Current Assets fell 62.18% to $16.3 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $16.3 million through Dec 2025, down 62.18% year-over-year, with the annual reading at $16.3 million for FY2025, 62.18% down from the prior year.
Lyra Therapeutics' Current Assets history spans 7 years, with the latest figure at $16.3 million for Q4 2025.
- Current Assets came in at $16.3 million for Q4 2025, down from $23.0 million in the prior quarter.
- In the past five years, Current Assets ranged from a high of $122.4 million in Q2 2022 to a low of $16.3 million in Q4 2025.
- The 5-year median for Current Assets is $68.4 million (2021), against an average of $69.8 million.
- Year-over-year, Current Assets soared 110.42% in 2022 and then plummeted 62.18% in 2025.
- Lyra Therapeutics' Current Assets stood at $47.9 million in 2021, then skyrocketed by 110.42% to $100.8 million in 2022, then grew by 3.96% to $104.8 million in 2023, then tumbled by 58.95% to $43.0 million in 2024, then tumbled by 62.18% to $16.3 million in 2025.
- Per Business Quant, the three most recent readings for LYRA's Current Assets are $16.3 million (Q4 2025), $23.0 million (Q3 2025), and $31.1 million (Q2 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - | 10.37 Mn |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - | 37.31 Mn |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn | 1.25 Bn |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | 73.04 Mn |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - | 3.59 Mn |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn | 11.73 Bn |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn | 18.21 Bn |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - | - |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn | 4.22 Bn |
| 10 | Lyra Therapeutics | - | - | - | 16.27 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 16.27 Mn |
| Sep 30, 2025 | 23.02 Mn |
| Jun 30, 2025 | 31.06 Mn |
| Mar 31, 2025 | 33.91 Mn |
| Dec 31, 2024 | 43.03 Mn |
| Sep 30, 2024 | 54.44 Mn |
| Jun 30, 2024 | 69.44 Mn |
| Mar 31, 2024 | 89.44 Mn |
| Dec 31, 2023 | 104.82 Mn |
| Sep 30, 2023 | 104.92 Mn |
| Jun 30, 2023 | 118.25 Mn |
| Mar 31, 2023 | 84.80 Mn |
| Dec 31, 2022 | 100.83 Mn |
| Sep 30, 2022 | 112.23 Mn |
| Jun 30, 2022 | 122.38 Mn |
| Mar 31, 2022 | 40.56 Mn |
| Dec 31, 2021 | 47.92 Mn |
| Sep 30, 2021 | 60.89 Mn |
| Jun 30, 2021 | 70.07 Mn |
| Mar 31, 2021 | 67.35 Mn |
| Dec 31, 2020 | 75.92 Mn |
| Sep 30, 2020 | 83.56 Mn |
| Jun 30, 2020 | 89.31 Mn |
| Mar 31, 2020 | 35.54 Mn |
| Dec 31, 2019 | 10.12 Mn |